Serial 79239066
Live / Registered — Registered (as of 08 Oct 2019)
What this means for you
Registered since 08 Oct 2019. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 79239066
- Registration number
- 5876245
- Mark type
- Design / logo
- Filed
- 22 May 2018
- Published for opposition
- 23 Jul 2019
- Registered
- 08 Oct 2019
- Attorney of record
- Alex Patel
Goods and services
- Class 005 — Pharmaceuticals: Chinese medicine nostrum in the nature of traditional Chinese medicines for treating influenza, depression, cough, diabetes, hypertension, respiratory diseases, cardiovascular disease, intestinal disorders, gastrointestinal diseases, hyperlipidemia, and hypercholesterolemia; medicines for human purposes, namely, medicines for treating hepatitis, dizziness, cardiovascular diseases, cerebrovascular diseases, depression, schizophrenia, insomnia, cholecystitis, gallstones, stomach diseases, digestive diseases, restlessness, laryngitis, pharyngitis, tonsillitis, tracheitis, pneumonia, influenza, cough, diabetes, nephropathy, eye diseases, vision loss and blindness in the elderly; chemico-pharmaceutical preparations for treating hepatitis, dizziness, cardiovascular diseases, cerebrovascular diseases, depression, schizophrenia, insomnia, cholecystitis, gallstones, stomach diseases, digestive diseases, restlessness, laryngitis, pharyngitis, tonsillitis, tracheitis, pneumonia, influenza, cough, diabetes, nephropathy, eye diseases, vision loss and blindness in the elderly; pharmaceutical preparations for treating hepatitis, dizziness, cardiovascular diseases, cerebrovascular diseases, depression, schizophrenia, insomnia, cholecystitis, gallstones, stomach diseases, digestive diseases, restlessness, laryngitis, pharyngitis, tonsillitis, tracheitis, pneumonia, influenza, cough, diabetes, nephropathy, eye diseases, vision loss and blindness in the elderly; active ingredient, namely, dietary fiber for use in the manufacture of pharmaceuticals for treating hepatitis, dizziness, cardiovascular diseases, cerebrovascular diseases, depression, schizophrenia, insomnia, cholecystitis, gallstones, stomach diseases, digestive diseases, restlessness, laryngitis, pharyngitis, tonsillitis, tracheitis, pneumonia, influenza, cough, diabetes, nephropathy, eye diseases, vision loss and blindness in the elderly; biochemical drugs for treating cancer and eye diseases; chemical preparations for pharmaceutical purposes, namely, chemical preparations for treating hepatitis, dizziness, cardiovascular diseases, cerebrovascular diseases, depression, schizophrenia, insomnia, cholecystitis, gallstones, stomach diseases, digestive diseases, restlessness, laryngitis, pharyngitis, tonsillitis, tracheitis, pneumonia, influenza, cough, diabetes, nephropathy, eye diseases, vision loss and blindness in the elderly; nutritive substances for microorganisms for medical purposes
Owner
Prosecution history
- 08 Oct 2024 — COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
- 05 Jun 2021 — NEW REPRESENTATIVE AT IB RECEIVED
- 13 Mar 2020 — FINAL DECISION TRANSACTION PROCESSED BY IB
- 04 Feb 2020 — GENERIC MADRID TRANSACTION SENT TO IB
- 04 Feb 2020 — GENERIC MADRID TRANSACTION CREATED
- 08 Jan 2020 — FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
- 08 Oct 2019 — REGISTERED-PRINCIPAL REGISTER
- 02 Aug 2019 — NOTIFICATION PROCESSED BY IB
- 23 Jul 2019 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 23 Jul 2019 — PUBLISHED FOR OPPOSITION
- 17 Jul 2019 — NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
- 17 Jul 2019 — NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
- 03 Jul 2019 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 19 Jun 2019 — ASSIGNED TO LIE
- 07 Jun 2019 — APPROVED FOR PUB - PRINCIPAL REGISTER